Identifying novel transcript biomarkers for hepatocellular carcinoma (HCC) using RNASeq datasets and machine learning

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death in the world owing to limitations in its prognosis. The current prognosis approaches include radiological examination and detection of serum biomarkers, however, both have limited efficiency and are ineffective in early prognosis.